Skip to main content icon/video/no-internet

ADVOCACY FOR STEM cells, in its broadest sense, means people getting together to discuss how the scientific and clinical potential of the cells can be moved forward. Advocates for stem cell research are often associated with an interest in a specific disease for which stem cells may offer some hope. Many of the debates have centered on embryonic stem cell research where the ethical issues associated with the isolation of embryonic stem cells pitch religious groups against patient advocates. Because adult stem cell research does not involve the destruction of embryos there is little opposition to this research—although advocacy is always useful to push a field forward.

Debates on stem cell research have been carried by governmental agencies, politicians, interest groups, clergy, religious organizations, scientists, businesses, and individuals. These have included pro—life advocates, bioethicists, the papacy, patient advocate groups, and even U.S. President George W. Bush. The main areas of stem cell advocacy have been scientific, ethical, political, commercial, and personal. Issues generated in each of these areas have attracted different advocates.

Organizations

Physicians hope to someday have new therapies that can mitigate or even cure diseases that today are incurable or at best managed—the new field of “regenerative medicine.” There are a large number of voluntary associations representing people with a variety of specific health issues (for example, the Michael J. Fox Foundation for Parkinson's Disease), or are more general, such as the American Association of Retired Persons (AARP). They have either touted stem cells as the ultimate cure, or expressed concerns over the dangers posed by as—of—yet unknown risks of the use of stem cells in treatments. For example, embryonic stem cells implanted in humans last a lifetime and may pose cancer risks or have other unintended consequences.

Discussions by advocates in the media about stem cells garners much public interest, and their concerns may gain public hearing before health organizations such as the Food and Drug Administration, which ultimately gives permission for all medicines, including those made from stem cells, to be allowed on the market for patient use.

Among those individuals who have advocated a broad approach to stem cell research were the late Christopher Reeve and his wife Dana Reeve and Michael J. Fox. After his spinal cord injury in an equestrian event, Christopher Reeve created the Christopher Reeve Foundation (CDRF). The foundation is a charity that promotes spinal cord injury research, which includes stem cell research. It is also an advocate of the election of “pro—science” presidents of the United States who will give unqualified support to stem cell research. Michael J. Fox was diagnosed with Parkinson's disease in the late 1990s and started a foundation that supports the use of stem cells for the treatment of Parkinson's disease and funded many studies in the early part of 2000.

The Coalition for the Advancement of Medical Research (CAMR) is a coalition of over 100 organizations that lobby for stem cell research. The organizations in CAMR include colleges and universities, patient organizations, scientific societies, foundations, and other organizations. It lobbies Congress, the federal bureaucracy, and the president when a hearing can be obtained. CAMR is an advocate for embryonic as well as adult stem cell research. The Genetics Policy Institute (GPI) was founded by lawyer Bernard Seigal and spawned the powerful advocacy group known as the Pro—Cures Movement. These organizations are attempting to lobby the public to get interested in stem cell research through education and debate.

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading